Evaluation of the immunohistochemical stain patterns of survivin, Bak and Bag-1 in colorectal cancers and comparison with polyps situated in the colon

Hepato-Gastroenterology

Volumn 55, Issue 85, 2008, Pages 1269-1273

  Alper, Murat ^a   Çukur, Selma ^b   Belenli, Olcay ^c   Suna, Mazlume ^d  

^a Diskapi Children's Hospital   (Turkey)

^b Izzet Baysal University   (Turkey)

^c ANKARA NUMUNE HOSPITAL   (Turkey)

^d Bal kl göl Public Hospital   (Turkey)

Author keywords

Bag 1; Bak; Colorectal carcinomas; Colorectal polyps; Immunohistochemistry; Survivin

Indexed keywords

BAK1 PROTEIN, HUMAN; BCL2 ASSOCIATED ATHANOGENE 1 PROTEIN; BCL2-ASSOCIATED ATHANOGENE 1 PROTEIN; BIRC5 PROTEIN, HUMAN; DNA BINDING PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN BAK; TRANSCRIPTION FACTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CASE CONTROL STUDY; COLON POLYP; COLON TUMOR; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; COLONIC POLYPS; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; TRANSCRIPTION FACTORS;

EID: 58149378209     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Steller H: Mechanisms and genes of cellular suicide. Science 1995; 267:1445-1449.
2. Granville DJ, Carthy CM, Hunt DW: Apoptosis: molecular aspects of cell death and disease. Lab Invest 1998; 78:893-913. (Pubitemid 28378205)
3. Sjörstöm J, Bergh J: How apoptosis is regulated and what goes wrong in cancer. BMJ 2001; 322:1538-1539. (Pubitemid 32588354)
4. Crawford JM: The gastrointestinal system. In: Cotran R, Kumar V, Collins T (Eds). Robbins Pathologic Basis of Disease. 6th Edition. Philadelphia, USA: WB Saunders Co., 1999; pp. 775-845.
5. Republic of Turkey, Ministry of Health, Cancer Control Department: Kanserle savas politikasi ve kanser verileri, 1995-99 [report in Turkish: Cancer control policy and cancer data 1995-99] Report no: 618; Ankara 2002.
6. Townsend PA, Dublin E, Hart IR, et al.: BAG-1 expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data. J Pathol 2002; 197:51-59. (Pubitemid 34450164)
7. Cutress RI, Townsend PA, Brimmell M: BAG-1 expression and function in human cancer. Br J Cancer 2002; 87:834-839. (Pubitemid 35252957)
8. Kikuchi R, Noguchi T, Takeno S, et al.: Nuclear BAG-1 expression reflects malignant potential in colorectal carcinomas. Br J Cancer 2002; 87:1136-1139. (Pubitemid 35418109)
9. Tang SC, Shaheta N, Chernenko, et al.: Expression of BAG-1 in invasive breast carcinomas. J Clin Oncol 1999; 17:1710-1719.
10. Rorke S, Murphy S, et al.: Prognostic significance of BAG-1 expression in non-small cell lung cancer. Int J Cancer 2001; 95(5):317-322. (Pubitemid 32847043)
11. Turner BC, Krajewski S, Krajewska M, et al.: BAG-1: A novel biomarker predicting long term survival in early stage breast cancer. J Clin Oncol 2001; 19:992-1000. (Pubitemid 32176273)
12. Ito Y, Yoshida H, Nakano K, et al.: A. Bag-1 expression in thyroid neoplasm: its correlation with Bcl-2 expression and carcinoma dedifferentiation. Anticancer Res 2003; 23(1B):569-576. (Pubitemid 36358453)
13. Shindoh M, Adachi M, Higashino F, et al.: BAG-1 expression correlates highly with the malignant potential in early lesions (T1 and T2) of oral squamous cell carcinoma. Oral Oncol 2000; 36:444-449. (Pubitemid 30645979)
14. Ogura S, Senzaki H, Yamamoto D, et al.: Prognostic significance of Bcl-2, Bcl-xl/s, Bax and Bak expressions in colorectal carcinomas. Oncol Rep 1999; 6(2):365-369.
15. Krajewski S, Krajewska M, Reed JC: Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res 1996; 56:2849-2855. (Pubitemid 26175747)
16. Krajewska M, Moss SF, Krajewski S: Elevated expression of Bcl-x and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996; 56:2422-2427. (Pubitemid 26154093)
17. Zapata JM, Krajewska M, Krajewski S, et al.: Expression of multiple apoptosis regulatory genes in human breast cancer cell lines and primary tumors. Breast Cancer Res Treat 1998; 47:129-140. (Pubitemid 28046084)
18. Sarela AI, Macadam RCA, Farmery SM, et al.: Expression of the antiapoptosis gene survivin predicts death from recurrent colorectal carcinoma. Gut 2002; 46:645-650.
19. Sarela AI, Scott N, Ramsdale J et al.: Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol 2001; 8(4):305-310. (Pubitemid 32422855)
20. Agui T, McConkey DJ, Tanigawa N: Comparative study of various biological parameters, including expression of survivin, between primary and metastasis human colonic adenocarcinomas. Anticancer Res 2002; 22(3):1769-1776. (Pubitemid 34839194)
21. Tanaka K, Iwamato S, Gon G, et al.: Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 2000; 6:127-134. (Pubitemid 30064984)
22. Chiodino C, Cesinaro AM, Ottani D, et al.: Expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J Invest Dermatol 1999; 113:415-418. (Pubitemid 29449083)
23. Cohen C, Lohmann CM, Cotsonis G, et al.: Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis. Mod Pathol 2003; 16:574-583. (Pubitemid 36718439)
24. Takai N, Miyazaki T, Nishida M, et al.: Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Cancer Lett 2002; 184:105-116. (Pubitemid 34718112)